Onc­ter­nal stops can­cer tri­als and be­gins search for fu­ture busi­ness op­tions

Af­ter dis­ap­point­ing ef­fi­ca­cy da­ta and a pa­tient death, Onc­ter­nal Ther­a­peu­tics is dis­con­tin­u­ing two tri­als and look­ing for strate­gic al­ter­na­tives.

The San Diego com­pa­ny said it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER